AOD-9604 (hGH Fragment 176-191)
Also known as: AOD-9604, AOD9604, hGH Fragment 176-191, hGH Frag 176-191, Anti-Obesity Drug 9604
Synthetic fragment of human GH (residues 176-191) that stimulates fat breakdown without affecting blood glucose, IGF-1, or insulin sensitivity. Targets fat cells selectively.
Pharmacokinetics
- Half-life
- 3 min
- Time to peak
- 15 min
- Bioavailability
- 70%
- Onset
- 15 min
- Dosing interval
- 24h
Administration
- Primary routes
- SubQ, Oral
- Category
- Metabolic
Safety Flags
- High immunogenicity
- Contraindicated in cancer history
Storage
- · Requires refrigeration (2–8°C)
- · Temperature sensitive — minimise room-temp exposure
Used in 2 outcome protocols
- Fat Loss (Lipolysis)Primary
Accelerate fat metabolism and lipolysis without affecting growth hormone levels
Safe default: 250mcg · daily · SubQ
- Injury Repair
Accelerate healing of tendons, ligaments, muscles, and other soft tissues
Safe default: 250mcg · daily · SubQ
Simulate AOD-9604 (hGH Fragment 176-191)
Pinned.life runs a 1-compartment Bateman pharmacokinetic simulation against 38 peptides in real time. Build a stack, see serum-level curves, get warned about peak overlaps and drug-peptide interactions.